Evidence map›Paper›PMID 34637469›Full record

ArticlePloS one2021

Pathophysiology and inflammatory biomarkers of sulfur mustard-induced corneal injury in rabbits.

Dinesh G Goswami, Neha Mishra, Rama Kant, Chapla Agarwal, Claire R Croutch, Robert W Enzenauer, Mark J Petrash, Neera Tewari-Singh, Rajesh Agarwal

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
4.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Dinesh G GoswamiDepartment of Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States of America.
Neha MishraDepartment of Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States of America.
Rama KantDepartment of Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States of America.
Chapla AgarwalDepartment of Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States of America.
Claire R CroutchMedical Countermeasures Division, MRIGlobal, Kansas City, Missouri, United States of America.
Robert W EnzenauerDepartment of Ophthalmology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States of America.
Mark J PetrashDepartment of Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States of America.
Neera Tewari-SinghDepartment of Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States of America.
Rajesh AgarwalDepartment of Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States of America.ORCID 0000-0002-9455-0235
University of Colorado Anschutz Medical Campus · USMRIGlobal · US

Funding

Effective Therapies for Ocular Injuries by Vesicating AgentsU01EY023143 · NEI · UNIVERSITY OF COLORADO DENVER · PI AGARWAL, RAJESH · 2012 to 2016
$3.9M
Dexamethasone as an Effective Therapy for Ocular Injuries by Vesicating Agents.U01EY030405 · NEI · UNIVERSITY OF COLORADO DENVER · PI AGARWAL, RAJESH · 2020 to 2023
$2.9M
Targeted Therapeutic Approaches to Counteract Toxicity from Phosgene Oxime Skin ExposureU01AR075470 · NIAMS · MICHIGAN STATE UNIVERSITY · PI TEWARI-SINGH, NEERA · 2019 to 2021
$1.4M
NEI NIH HHS U01 EY023143NEI NIH HHS U01 EY030405
6 · The paper itself

Abstract

Sulfur mustard (SM) is a cytotoxic, vesicating, chemical warfare agent, first used in 1917; corneas are particularly vulnerable to SM exposure. They may develop inflammation, ulceration, neovascularization (NV), impaired vision, and partial/complete blindness depending upon the concentration of SM, exposure duration, and bio-physiological conditions of the eyes. Comprehensive in vivo studies have established ocular structural alterations, opacity, NV, and inflammation upon short durations (<4 min) of SM exposure. In this study, detailed analyses of histopathological alterations in corneal structure, keratocytes, inflammatory cells, blood vessels, and expressions of cyclooxygenase (COX)-2, matrix metalloproteinase (MMP)-9, vascular endothelial growth factor (VEGF), and cytokines were performed in New Zealand white rabbits, in a time-dependent manner till 28 days, post longer durations (5 and 7 min) of ocular SM exposure to establish quantifiable endpoints of injury and healing. Results indicated that SM exposure led to duration-dependent increases in corneal thickness, opacity, ulceration, epithelial-stromal separation, and epithelial degradation. Significant increases in NV, keratocyte death, blood vessels, and inflammatory markers (COX-2, MMP-9, VEGF, and interleukin-8) were also observed for both exposure durations compared to the controls. Collectively, these findings would benefit in temporal delineation of mechanisms underlying SM-induced corneal toxicity and provide models for testing therapeutic interventions.

Indexed as

AnimalsBiomarkersBlood VesselsCell SurvivalChemical Warfare AgentsCorneaCorneal InjuriesCorneal KeratocytesCyclooxygenase 2Interleukin-8Matrix Metalloproteinase 9Mustard GasRabbitsBiomarkersChemical Warfare AgentsCyclooxygenase 2Interleukin-8Matrix Metalloproteinase 9Mustard Gas

Identifiers

PMID34637469
PMCPMC8509852
OpenAlexW3206757772

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.